|
|
Post by M. Hawbaker on Jan 14, 2023 22:40:43 GMT
Moderna is developing an mRNA shot that is injected directly into the hearts of heart attack and heart failure patients. The 'vaccine' uses the same technology as the company's flagship Covid jab and is designed for people weeks or months after a heart attack to help them recover. It works by instructing human heart cells to generate a hormone that is known to improve blood flow, helping restore damaged heart muscles. Moderna CEO Stéphane Bancel told Sky News Australia in October: 'We have now in the clinic a super exciting program where we inject mRNA into people's hearts after a heart attack to grow back new blood vessels to help revascularize the heart. 'It's a bit like science fiction medicine but that's what is really exciting to me.' www.dailymail.co.uk/health/article-11627695/Moderna-begins-trialing-mRNA-shot-injected-directly-HEART.html |
|
|
|
Post by M. Hawbaker on Jan 14, 2023 22:43:28 GMT
Speaking as someone with a history of heart problems, I will not be taking this.  |
|
|
|
Post by barb43 on Jan 14, 2023 22:47:35 GMT
The title of this thread made my heart drop into my stomach, and took away my breath.
It's a terrifying idea that those ghouls will now begin killing people with smiles on their faces and faux concern in their voices as if they're going to be helping people, saving people.
Mm, nope - I don't want to ever take anything that includes an mRNA component. Let me die when God calls me home - I have a far better place to go!
|
|
|
|
Post by barb43 on Jan 14, 2023 23:43:37 GMT
I'll be watching for more on this topic, believe me!
|
|
|
|
Post by M. Hawbaker on Jan 14, 2023 23:52:56 GMT
MODERNA ANNOUNCES ADVANCES ACROSS MRNA PIPELINE AND PROVIDES BUSINESS UPDATE]CAMBRIDGE, MA / ACCESSWIRE / January 9, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced updates on its industry-leading mRNA pipeline. Moderna continues to scale, now with 48 programs in development, including 36 programs in clinical trials encompassing mRNA infectious disease vaccines and mRNA therapeutics spanning seven different modalities. "We enter 2023 in a great position, with significant momentum across our clinical pipeline, a highly energized team and a strong balance sheet of over $18 billion of cash and cash equivalents," said Stéphane Bancel, Chief Executive Officer of Moderna. "With our infectious disease franchise continuing to accelerate with exciting near-term catalysts for RSV Phase 3 data and Flu Phase 3 data, and recent breakthroughs in the development of individualized cancer treatments, as well as our rapid advancement in rare diseases and promising cardiology programs, the Moderna platform is delivering across several modalities. Our progress is meeting the high expectations we set out a few years ago, and with encouraging clinical data across the entire Moderna platform, we are accelerating our investments to deliver the greatest possible impact to people through mRNA medicines. Our board has approved a significant increase to our R&D investments, with a budget for 2023 of around $4.5 billion. 2023 is going to be a very exciting year for Moderna, and most importantly, for patients." investors.modernatx.com/news/news-details/2023/Moderna-Announces-Advances-Across-mRNA-Pipeline-and-Provides-Business-Update/default.aspxI'm starting to think that maybe this whole Covid vax business was just a test run for some major genetic tampering by the powers that be. The term "transhumanism" come to mind yet again.  
|
|
|
|
Post by warriorchild on Jan 15, 2023 0:43:19 GMT
Agree Mel
Just another step towards :-X
Praying
|
|
